Syndax Pharmaceuticals Inc SNDX Fundamentals and Key Ratios

Syndax Pharmaceuticals Inc. (SNDX) Fundamentals


Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

SHARE INFORMATION
Market Cap	$ 1,459,195,635
Shares Outstanding	68,442,572
Float	67,685,410
Percent Float	98.89%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 0
Latest Fiscal EPS	$ -2.45
Latest Fiscal Date	2022-12-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	-

HOLDERS
Institutions	371
Institutional Holdings Date	2023-02-28
Institutional Bought Previous 3 Months	19,607,024
Institutional Holdings Percent	137.6%
Institutional Sold Previous 3 Months	4,678,892
Insider Holdings Date	2023-02-28
Insider Bought Previous 3 Months	1,248,882
Insider Holdings Percent	0.6
Insider Sold Previous 3 Months	295,695
Insider Shares Owned	432,864

TRADING INFO
52 Week High	$ 29.86
52 Week Low	$ 13.27
52 Week High Change	$ 23.02
21 Day Moving Average	$ 22.9819
21 Day Extended Moving Average	$ 22.8831
50 Day Moving Average	$ 25.0176
50 Day Extended Moving Average	$ 23.9423
200 Day Moving Average	$ 23.1486
200 Day Extended Moving Average	$ 22.945
10 Day Average Volume	904,131
20 Day Average Volume	910,719
30 Day Average Volume	795,512
50 Day Average Volume	738,644
Alpha	0.026607
Beta	1.0394
Standard Deviation	0.194302
R2	0.082987
7 Day Price Change	$ -1.75
7 Day Percent Change	-7.59%
21 Day Price Change	$ -2.91
21 Day Percent Change	-12.01%
30 Day Price Change	$ -4.03
30 Day Percent Change	-15.9%
Month to Date Price Change	$ -4.03
Month to Date Percent Change	-15.9%
Quarter to Date Price Change	$ -4.13
Quarter to Date Percent Change	-16.23%
180 Day Price Change	$ -3.20
180 Day Percent Change	-13.05%
200 Day Price Change	$ -3.25
200 Day Percent Change	-13.23%
Year to Date Price Change	$ -4.13
Year to Date Percent Change	-16.23%

PROFITABILITY
EBIT Margin	-8.6%
EBITDA Margin	-8.5%
Pre-Tax Profit Margin	-2,648.1%
Profit Margin Count	-19.76%
Gross Margin	0.0%
Profit Margin TOT	-19.76%

INCOME STATEMENTS
Revenue	$ 0
Revenue Per Share	$ 0.00
Revenue (3 Years)	$ 0.00
Revenue (5 Years)	$ 0.00

FINANCIAL STRENGTH
Price to Tangible Book	3.20
Total Debt To Equity	0.00
Int Coverage	-46.60
Current Ratio	16.90
Leverage Ratio	1.10
Quick Ratio	16.80
Long Term Debt To Capital	0.00

VALUATION MEASURES
PE Ratio	118.10
Enterprise Value	$ 993,070,278
Price to Sales	0.00
Price to Free Cash	-11.00
PE High Last 5 Years	57.60
Price To Book	3.20
Price To Cash Flow	137.60
PE Low Last 5 Years	-6.90
Price to Tangible Book	3.20

MANAGEMENT EFFECTIVENESS
Receivables Turnover	0.00
Invoice Turnover	0.00
Assets Turnover	0.00
Return Assets	-32.42
Return on Equity	-35.03
Return on Capital	-4.94

PROFILE INFO
Issue Type	CS
SEC Type	EQS
Auditor	Deloitte & Touche LLP
CEO	Michael Metzger
Emplyoees	107
Last Audit	UQ
CIK	0001395937
Industry	Biotechnology
Sector	Healthcare
NAICS	Pharmaceutical Preparation Manufacturing(325412)

CONTACT INFO
Address	35 Gatehouse Drive Building D, Floor 3 Waltham, MA 2451
Website	https://www.syndax.com
Facsimile	+1 781 419-1420
Telephone	+1 781 419-1400
Email	ir@syndax.com

Boards:

Quotes:

SNDX